Princess Margaret Cancer Centre at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Princess Margaret Cancer Centre takes part in 11 sessions at ESMO 2026 in Madrid. Its program spans head and neck cancers, including HPV-related disease and nasopharyngeal carcinoma, and lung cancer, from liquid biopsies to ROS1-fused non-small cell lung cancer. Other sessions cover side effects of cellular therapy, HER2-positive gastroesophageal cancer and anxiety in patients with advanced cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
Princess Margaret Cancer Centre Toronto, Canada | |
Cancer hospital of University Health Network in Toronto, Canada, affiliated with the University of Toronto. | Talk Fri Oct 23 13:30–13:50 Presentation by Expert Lung & thoracic cancers Chair Fri Oct 23 13:30–14:30 Chair Sat Oct 24 08:30–10:00 Challenges in the treatment approach of HPV-related head and neck cancers Sarcoma, CNS, head & neck and rare cancers Abstract Sat Oct 24 08:57–09:02 Abstract Sat Oct 24 09:25–09:35 Talk Sat Oct 24 09:30–09:50 Talk Sat Oct 24 19:00–19:15 Unmet needs: Breakthroughs in first line systemic therapies for HER2+ disease Gastrointestinal cancersBiomarkers & precision oncology Talk Sun Oct 25 10:20–10:40 The role of medical oncologist Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 17:06–17:18 Invited Discussant LBA6 Lung & thoracic cancersGastrointestinal cancers Talk Sun Oct 25 19:05–19:25 Established therapeutic algorithms for patients with ROS1-fused advanced NSCLC Lung & thoracic cancers Talk Mon Oct 26 17:15–17:35 Anxiety and death anxiety Nursing & supportive care |
Instantly find 20 buyers from Princess Margaret Cancer Centre
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction